FDA Approved: LAMIVUDINE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s original application for lamivudine (generic), authorizing its marketing for HIV-1 infection and chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)